SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $31,000 | -11.4% | 3,750 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | -18.6% | 3,750 | -6.2% | 0.00% | – |
| Q2 2019 | $43,000 | -4.4% | 4,000 | -14.5% | 0.00% | – |
| Q1 2019 | $45,000 | +164.7% | 4,680 | +222.8% | 0.00% | – |
| Q4 2018 | $17,000 | -32.0% | 1,450 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | +78.6% | 1,450 | +52.6% | 0.00% | – |
| Q2 2018 | $14,000 | -62.2% | 950 | -51.0% | 0.00% | -100.0% |
| Q1 2018 | $37,000 | +15.6% | 1,940 | 0.0% | 0.00% | – |
| Q4 2017 | $32,000 | +113.3% | 1,940 | +94.0% | 0.00% | – |
| Q3 2017 | $15,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | +80.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |